[Use of maprotiline in the treatment of depressions in predominantly geriatric patients. Preliminary report].
D000367:Age Factors; D000368:Aged; D000873:Anthracenes / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012649:Self Concept; D014987:Xerostomia / Q000139:chemically induced
D000873:Anthracenes; D008376:Maprotiline
Uber den Einsatz von Maprotilin zur Behandlung von Depressionen bei einem überwiegend geriatrischen Krankengut. Vorläufige Mitteilung